Skip to main content
. 2016 Nov 10;9:6897–6907. doi: 10.2147/OTT.S120062

Figure 3.

Figure 3

Average anti-HBV medication costs in LAM and ADV groups at the end of 0, 1, 2, and 3 years of antiviral therapy.

Notes: Data were reported as per-patient-per-day due to variable follow-up periods. *P<0.05, LAM versus ADV groups.

Abbreviations: ADV, adefovir dipivoxil; LAM, lamivudine; HBV, hepatitis B virus.